AVROBIO, Inc. at WORLDSymposium 2019
Feb 6, 2019 at 5:30 PM EST
AVROBIO, Inc. announced that clinical trial updates related to the Company’s gene therapy program for AVR-RD-01 in Fabry disease will be presented at WORLDSymposium, an annual conference dedicated to lysosomal diseases, being held February 4-8, 2019 in Orlando, Florida. AVROBIO will host an event for analysts and investors in conjunction with the conference, with a presentation and webcast beginning at 5:30 p.m. ET on Wednesday, February 6, 2019 in addition to the data presentations made as part of the WORLDSymposium program.